HARBOUR INVESTMENTS, INC. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
HARBOUR INVESTMENTS, INC. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$7
-30.0%
70.0%0.00%
Q2 2023$10
-9.1%
70.0%0.00%
Q1 2023$11
-75.0%
70.0%0.00%
Q4 2022$447
-90.8%
0.00%
Q4 2021$0
-100.0%
76
-56.8%
0.00%
Q3 2021$2,000
-50.0%
1760.0%0.00%
Q2 2021$4,000
+100.0%
176
+131.6%
0.00%
Q1 2021$2,000760.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$27,840,84218.82%
Ikarian Capital, LLC 1,891,147$11,781,8462.84%
Altium Capital Management LP 620,000$3,862,6001.96%
Ikarian Capital, LLC 1,296,900$8,079,6871.95%
Parkman Healthcare Partners LLC 822,784$5,125,9441.36%
Deep Track Capital, LP 4,000,000$24,920,0001.05%
Monaco Asset Management SAM 470,100$2,928,7230.88%
BRAIDWELL LP 3,393,405$21,140,9130.71%
Telemetry Investments, L.L.C. 71,000$4420.70%
Rhenman & Partners Asset Management AB 900,000$5,607,0000.58%
View complete list of ESPERION THERAPEUTICS INC NE shareholders